GWM
DERM icon

Geneos Wealth Management’s Journey Medical DERM Stock Holding History

Geneos Wealth Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-63,280
Closed -$488K – 2494
2025
Q4 		$488K Hold
63,280
– – 0.01% 673
2025
Q3 		$451K Hold
63,280
– – 0.01% 681
2025
Q2 		$454K Sell
63,280
-63,280
-50% -$437K 0.01% 736
2025
Q1 		$747K Buy
126,560
+63,280
+100% +$311K 0.01% 761
2024
Q4 		$247K Hold
63,280
– – 0.01% 773
2024
Q3 		$358K Hold
63,280
– – 0.01% 628
2024
Q2 		$357K Buy
+63,280
New +$260K 0.02% 572

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geneos Wealth Management's DERM Position: Q1 2026 in Review

Geneos Wealth Management sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 63,280 shares — an estimated $488K sold.

Geneos Wealth Management first reported a position in DERM in Q2 2024 and held it in 7 quarters. The position peaked at $747K in Q1 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Geneos Wealth Management reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • Geneos Wealth Management sold 63,280 Journey Medical shares in Q1 2026, an estimated $488K.
  • Geneos Wealth Management first reported a position in Journey Medical in Q2 2024 and held it in 7 quarters.
  • Geneos Wealth Management's Journey Medical position peaked at $747K in Q1 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.